Denali Therapeutics Stock Price Prediction
| DNLI Stock | USD 15.56 0.55 3.41% |
Oversold Vs Overbought
41
Oversold | Overbought |
Denali Therapeutics stock price prediction is an act of determining the future value of Denali Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Denali Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Denali Therapeutics and does not consider all of the tangible or intangible factors available from Denali Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Denali Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Denali Therapeutics' stock price prediction:EPS Estimate Next Quarter (0.80) | EPS Estimate Current Year (2.60) | EPS Estimate Next Year (2.59) | Wall Street Target Price 41.19 | Quarterly Revenue Growth (1.00) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Denali Therapeutics based on different types of headlines from major news networks to social media. The Denali stock price prediction module provides an analysis of price elasticity to changes in media outlook on Denali Therapeutics over a specific investment horizon. Using Denali Therapeutics hype-based prediction, you can estimate the value of Denali Therapeutics from the perspective of Denali Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Denali Therapeutics using Denali Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Denali using crowd psychology based on the activity and movement of Denali Therapeutics' stock price.
Denali Therapeutics Implied Volatility | 0.0 |
Denali Therapeutics' implied volatility exposes the market's sentiment of Denali Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Denali Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Denali Therapeutics stock will not fluctuate a lot when Denali Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Denali Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Denali Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Denali because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Denali Therapeutics after-hype prediction price | USD 16.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Denali contract
Based on the Rule 16, the options market is currently suggesting that Denali Therapeutics will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-05-17 option contract. With Denali Therapeutics trading at USD 15.56, that is roughly USD 0.0 . If you think that the market is fully incorporating Denali Therapeutics' daily price movement you should consider acquiring Denali Therapeutics options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Denali |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Denali Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Denali Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Denali Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Denali Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Denali Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Denali Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Denali Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Denali Therapeutics' historical news coverage. Denali Therapeutics' after-hype downside and upside margins for the prediction period are 10.04 and 22.18, respectively. We have considered Denali Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Denali Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Denali Therapeutics is based on 3 months time horizon.
Denali Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Denali Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Denali Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Denali Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 6.08 | 0.00 | 0.00 | 10 Events / Month | 16 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
15.56 | 16.11 | 0.00 |
|
Denali Therapeutics Hype Timeline
Denali Therapeutics is currently traded for 15.56. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Denali is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Denali Therapeutics is about 4004.79%, with the expected price after the next announcement by competition of 15.56. About 14.0% of the company shares are held by company insiders. The book value of Denali Therapeutics was currently reported as 7.45. The company recorded a loss per share of 1.06. Denali Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out Denali Therapeutics Basic Forecasting Models to cross-verify your projections.Denali Therapeutics Related Hype Analysis
Having access to credible news sources related to Denali Therapeutics' direct competition is more important than ever and may enhance your ability to predict Denali Therapeutics' future price movements. Getting to know how Denali Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Denali Therapeutics may potentially react to the hype associated with one of its peers.
Denali Therapeutics Additional Predictive Modules
Most predictive techniques to examine Denali price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Denali using various technical indicators. When you analyze Denali charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Denali Therapeutics Predictive Indicators
The successful prediction of Denali Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Denali Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Denali Therapeutics based on analysis of Denali Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Denali Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Denali Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 20.64 | 22.03 | 13.36 | 12.69 | Receivables Turnover | 39.69 | 21.69 | 122.42 | 128.54 |
Story Coverage note for Denali Therapeutics
The number of cover stories for Denali Therapeutics depends on current market conditions and Denali Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Denali Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Denali Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Denali Therapeutics Short Properties
Denali Therapeutics' future price predictability will typically decrease when Denali Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Denali Therapeutics often depends not only on the future outlook of the potential Denali Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Denali Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 137.4 M | |
| Cash And Short Term Investments | 1 B |
Check out Denali Therapeutics Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.06) | Revenue Per Share 2.406 | Quarterly Revenue Growth (1.00) | Return On Assets (0.09) | Return On Equity (0.14) |
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.